Profil
Christopher Seiter worked as the Chief Financial Officer at Trevi Therapeutics, Inc. from 2018 to 2021.
Prior to that, he held the same position at Millendo Therapeutics, Inc. He also worked as MD & Head-Life Sciences Investment Banking at Bank of America Merrill Lynch (New York).
Seiter completed his undergraduate degree at the University of Rochester.
Anciens postes connus de Christopher Seiter
| Sociétés | Poste | Fin |
|---|---|---|
| TREVI THERAPEUTICS, INC. | Directeur Financier/CFO | 02/04/2021 |
Bank of America Merrill Lynch (New York)
Bank of America Merrill Lynch (New York) Regional BanksFinance Provides corporate, investment banking and wealth management services | Corporate Officer/Principal | - |
| MILLENDO THERAPEUTICS | Directeur Financier/CFO | - |
Formation de Christopher Seiter
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Rochester Christian University
Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trevi Therapeutics, Inc.
Trevi Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treatment for cough conditions | Health Technology |
Bank of America Merrill Lynch (New York)
Bank of America Merrill Lynch (New York) Regional BanksFinance Provides corporate, investment banking and wealth management services | Finance |
Millendo Therapeutics, Inc.
Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
















